Joel F. Sussman
Director/Board Member presso Galera Therapeutics Australia Pty Ltd.
Profilo
Joel F.
Sussman is currently the Director at Galera Therapeutics Australia Pty Ltd.
and the Treasurer at Vascular Magnetics, Inc. He previously worked as the Chief Financial Officer at CDNOW, Inc., PhaseBio Pharmaceuticals, Inc., Valeo Medical, Inc., NuPathe, Inc., Immunome, Inc., Synbody Biotechnology, Inc., Ascenta Therapeutics, Inc., Neuro Diagnostic Devices, Inc., Garnet BioTherapeutics, Inc., Oncopia Therapeutics, Inc., and Five Eleven Pharma, Inc. He was also the Chief Financial Officer & Treasurer at Galera Therapeutics, Inc. from 2012 to 2019.
Mr. Sussman received his undergraduate degree from Yale University and his MBA from The Wharton School of the University of Pennsylvania.
Posizioni attive di Joel F. Sussman
| Società | Posizione | Inizio |
|---|---|---|
Vascular Magnetics, Inc.
 Vascular Magnetics, Inc. Medical DistributorsDistribution Services Vascular Magnetics, Inc. develops novel therapeutic products. Its VMI contains a magnetic targeting catheter, an apparatus that generates a uniform magnetic field around the leg, and biodegradable magnetic particles that contain a drug that blocks re-obstruction of the artery. The company was founded by Richard S. Woodward and Robert J. Levy in 2010 and is headquartered in Philadelphia, PA. | Treasurer | - |
| Galera Therapeutics Australia Pty Ltd. | Director/Board Member | - |
Precedenti posizioni note di Joel F. Sussman
| Società | Posizione | Fine |
|---|---|---|
| PHASEBIO PHARMACEUTICALS, INC. | Director of Finance/CFO | 18/04/2016 |
| Five Eleven Pharma, Inc. | Director of Finance/CFO | - |
Oncopia Therapeutics, Inc.
 Oncopia Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Oncopia Therapeutics LLC engages in biotechnology research. The company was founded in 2017 and is headquartered in Malvern, PA. | Director of Finance/CFO | - |
| IMMUNOME, INC. | Director of Finance/CFO | - |
| GALERA THERAPEUTICS, INC. | Director of Finance/CFO | 01/04/2019 |
Formazione di Joel F. Sussman
| Yale University | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| PHASEBIO PHARMACEUTICALS, INC. | Health Technology |
| IMMUNOME, INC. | Health Technology |
| GALERA THERAPEUTICS, INC. | Health Technology |
| Aziende private | 11 |
|---|---|
CDNOW, Inc.
 CDNOW, Inc. Electronics/Appliance StoresRetail Trade CDNOW, Inc. provides compact discs and other music-related products. It operates as an electronic commerce retailer of pre-recorded music, including compact discs and digital downloads, and other entertainment-related products, as well as a source of entertainment-related content. The company was founded in 1994 and is located in New York. | Retail Trade |
Valeo Medical, Inc.
 Valeo Medical, Inc. Medical SpecialtiesHealth Technology Valeo Medical, Inc. develops non-invasive serum diagnostic for endometriosis, a chronic painful disease that affects women of child-bearing age. It products address the needs of millions of women who suffer with endometriosis. The company was founded by Frederick J. Fritz & Debra A. Peattie in 2003 and is located in Burlington, MA. | Health Technology |
NuPathe, Inc.
 NuPathe, Inc. Medical SpecialtiesHealth Technology NuPathe, Inc. develops pharmaceutical and therapeutic products. It focuses on the development and commercialization of branded therapeutics for diseases of central nervous system, including neurological and psychiatric disorders. The company was founded by Terri B. Sebree and Jane Holmes Hollingsworth in 2005 and is headquartered in Malvern, PA. | Health Technology |
Synbody Biotechnology, Inc.
 Synbody Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology Synbody Biotechnology, Inc. operates as a platform for the discovery and development of novel and attractive molecules. The company was founded by Paul L. Hallenbeck, Chris Diehnelt, Kevin D. Burroughs and Stephen Albert Johnston in 2010 and is headquartered in Chester Springs, PA. | Health Technology |
Ascenta Therapeutics, Inc.
 Ascenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ascenta Therapeutics, Inc. engages in the discovery and development of medicines for cancer. Its core technology consists of agents designed to re-establish the natural program of apoptosis (cell death) in abnormal cancer cells. Its has three small molecule programs against distinct apoptosis targets: Bcl-2 (AT-101 – an oral pan-Bcl2 inhibitor), IAP (AT-406 – an oral multi-IAP inhibitor) and HDM2. The company was founded by Dajun Yang, Marc E. Lippman, and Shaomeng Wang on June 5, 2006 and is headquartered in Malvern, PA. | Health Technology |
Neuro Diagnostic Devices, Inc.
 Neuro Diagnostic Devices, Inc. Medical SpecialtiesHealth Technology Neuro Diagnostic Devices, Inc. provides medical devices. Its product ShuntCheck is an aid to the detection of flow in implanted cerebrospinal fluid (CSF) shunts. The company was founded by Samuel R. Neff and Frederick J. Fritz on May 16, 2005 and is headquartered in Princeton, NJ. | Health Technology |
Garnet BioTherapeutics, Inc.
 Garnet BioTherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Garnet BioTherapeutics, Inc. develops products that speed healing and reduce scarring after surgery or dermatologic procedures. It is a clinical stage regenerative medicine company that discovers, develops, and delivers new regenerative therapies by leveraging the intrinsic ability of adult somatic cells to repair, regenerate, and remodel tissue in acute and chronic disease settings. The firm's manufacturing and technology platform is a scalable GMP-compliant manufacturing process that can be applied to multiple cell types including adult bone marrow-derived stromal cells, smooth and skeletal muscle cells, dermal fibroblasts, chondrocytes, pre-adipocytes, and endothelial cells. The company was founded by Hubert J.P. Schoemaker on November 26, 2003 and is headquartered in Malvern, PA. | Commercial Services |
Oncopia Therapeutics, Inc.
Oncopia Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Oncopia Therapeutics LLC engages in biotechnology research. The company was founded in 2017 and is headquartered in Malvern, PA. | Commercial Services |
| Five Eleven Pharma, Inc. | |
| Galera Therapeutics Australia Pty Ltd. | |
Vascular Magnetics, Inc.
Vascular Magnetics, Inc. Medical DistributorsDistribution Services Vascular Magnetics, Inc. develops novel therapeutic products. Its VMI contains a magnetic targeting catheter, an apparatus that generates a uniform magnetic field around the leg, and biodegradable magnetic particles that contain a drug that blocks re-obstruction of the artery. The company was founded by Richard S. Woodward and Robert J. Levy in 2010 and is headquartered in Philadelphia, PA. | Distribution Services |
- Borsa valori
- Insiders
- Joel F. Sussman
